Dendreon Corp fka DNDNQ

[ATCrunch]

my 2015 conservative forecast. 350 million revenue. 35 million profit. 1 billion bid/35 million=28 times price to earnings. Add in EU revenue, What it took to develop the drug and possible use of NOL's and you can easily get to a higher multiple. 50 million profit is only 20 p/e.

during 2016-2020 600 million revenue 80 million profit=12.5 p/e

Add in early sequence's trials and other treatments and revenue could grow higher. I'm not a expert in pipelines but it looks like they have clinical trials with Bristol Meyers and others. You can easily get to a 1-2 billion bid. I'm thinking 900m-2.4b